Press Releases Items Per Page 102550 Year None2018201720162015201420132012201120102007 04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting 04.13.18 Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting 03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update 03.05.18 Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences 02.26.18 Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018 02.22.18 Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting 02.01.18 Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca 01.10.18 Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer 11.11.17 Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting 11.07.17 Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update 11.07.17 Syndax to Present at the SITC 32nd Annual Scientific Meeting 10.31.17 Syndax to Announce Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7, 2017 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update
02.26.18 Syndax to Announce Fourth Quarter and Year-end 2017 Financial Results and Host Conference Call and Webcast on March 5, 2018
02.22.18 Syndax Announces Presentations at the 2018 American Association for Cancer Research Annual Meeting
01.10.18 Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
11.11.17 Syndax Pharmaceuticals Announces Presentation of Data from Immuno-oncology Clinical Trials at the Society for Immunotherapy of Cancer 32nd Annual Scientific Meeting
11.07.17 Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update
10.31.17 Syndax to Announce Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7, 2017
